Ex vivo skin model to study local immune reactions
CompanyGenoskin, Toulouse, France
With the ex-vivo skin model "NativeSkin" developed by Genoskin, the local immune response during skin treatment can be observed.
It has been shown that application of Viaskin Peanut (a band-aid for the therapy of peanut allergy) to the skin model leads to penetration of the antigen into the epidermis and its uptake by Langerhans cells within 24 hours.
NativeSkin, an immunocompetent human skin model to study antigen uptake and processing by Langerhans cells
contact@genoskin.com
Added on: 10-14-2020
[1] https://www.genoskin.com/latest-news-and-data/publications/immunocompetent-skin-model-allergen-uptake/[2] https://www.genoskin.com/latest-news-and-data/publications/immunocompetent-skin-model-allergen-uptake/[3] https://www.genoskin.com/en/tissue-samples/human-skin-models-nativeskin/
